Background and purpose: Metabolic syndrome and chronic kidney disease (CKD) have received attention as new risk factors for cardiovascular disease. This study evaluated differences in key risk factors between acute coronary syndrome (ACS) and stable angina pectoris (SAP) by using traditional coronary risk factors, metabolic syndrome, and CKD. Methods: Among 1890 consecutive patients admitted to our institution, we studied 140 patients with initially diagnosed ACS and 163 patients with initially diagnosed SAP and compared risk factors between the two groups. Next, the relationship between smoking status after the initial diagnosis of coronary artery disease (CAD) and the incidence of subsequent cardiac event was examined after discharge in 284 patients. Results: Adjusted multivariate analysis showed that only current smoking was an independent predictor of ACS (odds ratio, 2.20; 95% CI, 1.28-3.78; p = 0.004) among all risk factors we examined. Treatment with a calcium-channel blocker had a preventive effect on ACS (odds ratio, 0.44; 95% CI, 0.26-0.75; p = 0.003), but treatment with a beta-blocker did not. Patients who continued to smoke after CAD was diagnosed had a risk of cardiac events about 5 times that of smokers who quit (adjusted hazard ratio, 5.05; 95% CI, 1. 33-19.20 
Introduction
Smoking is a risk factor for coronary artery disease (CAD). The risk of acute myocardial infarction increases with the number of cigarettes smoked per day [1] [2] [3] . In addition, the risk of CAD decreases with smoking cessation. The risk for a second coronary event after acute myocardial infarction also decreases with smoking cessation [3] [4] [5] [6] [7] .
The main cause of CAD is atherosclerosis [8] [9] [10] . Multiple processes in addition to smoking are involved in the development of atherosclerosis [11, 12] . Many studies examining the prevention of CAD have focused on how the progression of atherosclerosis can be slowed. In recent years, metabolic syndrome and chronic kidney disease (CKD) have received attention as new risk factors for cardiovascular disease. Studies have shown that metabolic syndrome and CKD individually increase the risk of CAD and the cardiovascular mortality rate [13] [14] [15] [16] .
However, the risk factors for acute coronary syndrome (ACS) have not been definitively analyzed. Given traditional risk factors and newly identified risk factors, such as metabolic syndrome and CKD, whether smoking remains a powerful risk factor for ACS is unclear. What is the most important risk factor for the shift of the initial manifestation of CAD to ACS? ACS is a life-threatening condition, which often leads to sudden death. Therefore, preventing ACS is extremely important. In the present study, we attempted to determine the key risk factors associated with ACS, from among traditional risk factors and newly identified risk factors, by comparing the risk factors for ACS with those for stable angina pectoris (SAP). We then performed a follow-up study to examine the relationship between the key risk factors and subsequent cardiac events after the initial diagnosis of CAD.
Materials and methods

Subjects and design
From November 2004 through March 2007, coronary angiography was performed for 1890 consecutive patients at The Jikei University School of Medicine in Tokyo, Japan. From among them, the following patients were enrolled in the present study: those in whom stenosis of 75% or more, based on the American Heart Association classification, was detected in at least 1 epicardial coronary artery and those in whom CAD was diagnosed for the first time. Among patients with stable CAD in whom coronary artery stenosis of 75% or more was detected, those who had had a prior myocardial infarction were excluded. In addition, patients with coronary artery spasm in whom coronary artery stenosis of 75% or more was not detected were also excluded from this study.
First, patients were divided into 2 groups: those with ACS (ACS group) and those with SAP (SAP group). We examined the presence in each group of risk factors, including metabolic syndrome, CKD, and traditional coronary risk factors.
Next, patients who had undergone initial treatment and remained alive 3 months after discharge were re-divided according to the risk factor most strongly associated with ACS. The incidence of subsequent cardiac events was then examined.
The study protocol (20-251[5541] ) was approved by the ethics committee of The Jikei University School of Medicine.
Definition of acute coronary syndrome
ACS was defined as the presence of acute myocardial infarction or unstable angina pectoris [17] . The diagnosis of acute myocardial infarction referred to the ''Universal definition of myocardial infarction'' [18] and required the presence of any 2 of the following 3 criteria: (1) history of chest pain, oppression or discomfort lasting 20 min or longer; (2) typical electrocardiographic change (i.e. ST segment elevation greater than 0.1 mV in at least 1 standard lead or 2 precordial leads, ST segment depression greater than 0.1 mV in at least 2 leads, abnormal Q waves or T wave inversions in at least 2 leads); (3) an increased serum level of the MB fraction of creatine kinase equivalent to more than twice the upper limit of the normal range. All patients were hospitalized within 1 week of the onset of acute myocardial infarction. Unstable angina pectoris was diagnosed when patients had chest pain, oppression, or discomfort at rest within 72 h before hospitalization without an increase in the serum level of the MB fraction of creatine kinase to more than twice the upper limit of the normal range. SAP was diagnosed when patients did not have angina at rest.
Definitions of traditional risk factors
When patients were found to have CAD, each risk factor was examined. Hypertension was defined as the presence of any of the following: systolic blood pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg, or the use of antihypertensive agents. Dyslipidemia was diagnosed with the use of lipid-lowering agents, the presence of 1 or more of the following 3 lipid disorders at first fasting blood sampling or both: a low-density lipoprotein (LDL) cholesterol level ≥140 mg/dL, a triglyceride level ≥150 mg/dL, and a high-density lipoprotein (HDL) cholesterol level <40 mg/dL [19] . The level of LDL cholesterol was calculated with the Friedewald equation for patients with a serum triglyceride level <400 mg/dL [20] . Diabetes was diagnosed with the presence of any of the following: fasting plasma glucose level ≥126 mg/dL, casual plasma glucose level ≥200 mg/dL, or a history of diabetes. However, the fasting plasma glucose level in patients with ACS was determined after an inflammatory reaction had resolved. Obesity was defined as a body mass index ≥25 kg/m 2 [21] .
Information about the treatment of risk factors at the time of the first examination at our hospital was obtained from hospital medical records, questionnaires, and direct interview of patients. Medications started just after the onset of CAD symptoms were excluded.
Smoking status was assessed at the time of the first medical examination at our hospital on the basis of the information obtained from hospital medical records, a questionnaire, and direct interview of patients. Smokers were defined as patients who had smoked cigarettes for at least 1 year. From 3 months to 1 year after patients first underwent treatment and were discharged, we reassessed smoking status with the same methods 1 or more times. Patients were re-divided into 4 groups: persistent smokers, defined as those who continued smoking after discharge; quitting smokers, those who stopped smoking after discharge; former smokers, those who had stopped smoking before the first examination at our hospital; never smokers, those who had never smoked cigarettes. However, smoking cessation just after the onset of CAD symptoms was not taken into consideration.
Also, information about the history of stroke, peripheral arterial disease, malignancy, chronic obstructive pulmonary disease, and dialysis were obtained from hospital medical records, questionnaires, and direct interview of patients. Peripheral arterial disease was defined as the stenotic, occlusive, and aneurysmal diseases of the aorta and its branch arteries that supply the brain, visceral organs, and the limbs, exclusive of the coronary arteries [22] .
Definitions of metabolic syndrome and chronic kidney disease
Metabolic syndrome was diagnosed with the definition of the International Diabetes Federation [23] .
We estimated the glomerular filtration rate (GFR) from serum creatinine values using an abbreviated equation developed by the Japanese Society of Nephrology: estimated GFR (mL/min/1.73
739 if the patient was female] [24] . We defined proteinuria as a urine protein level of 1+ or greater by dipstick analysis and defined microalbuminuria as a spot urine albumin-to-creatinine ratio of 30-300 mg albumin/g creatinine. CKD was diagnosed with the presence of proteinuria or microalbuminuria, an estimated GFR <60 mL/min/1.73 m 2 , or both.
Definition of cardiac events
The treatment that was finally performed to de novo lesions in all patients was considered as the initial treatment. The initial treatment was defined as medical therapy only, successful percutanous coronary intervention, or initial coronary artery bypass grafting surgery. A subsequent cardiac event was defined as any of the following: new or recurrent fatal and nonfatal acute myocardial infarction, new or recurrent unstable angina pectoris, percutanous coronary intervention of a new lesion, unscheduled coronary artery bypass grafting surgery, new occurrence or exacerbation of heart failure requiring hospitalization, and cardiac death. Heart failure was diagnosed according to the Framingham criteria by 2 or more cardiologists [25] . Excluded as events were target lesion revascularization, percutaneous coronary intervention performed for graft stenosis or occlusion, and scheduled coronary artery bypass grafting surgery.
Statistical analysis
Continuous variables were compared by means of unpaired t-tests or one-way analysis of variance and are expressed as means ± SD. Categorical variables were compared by means of the chi-square test or Fisher's exact test and are expressed as percentages. Multivariate analysis for predictors of ACS among risk factors was performed with multiple regression tests. We also performed multivariate analysis with multiple regression tests for drugs possibly preventing ACS among the medications used to treat risk factors. Cumulative cardiac event-free survival curves for each re-divided group were estimated with the Kaplan-Meier method. Event time was the time from discharge from our hospital after initial treatment to the occurrence of the first cardiac event. Survival curves were compared by means of the log-rank test. The association of re-divided groups with cardiac events was assessed with the multivariate Cox proportional hazards model. Statistical significance was indicated by a p-value less than 0.05. The SPSS, version 11.5, software package (SPSS Inc., Chicago, IL, USA) was used to perform all statistical analyses.
Results
Characteristics of the patients with acute coronary syndrome
Among 1890 consecutive patients, we studied 303 patients in whom CAD was diagnosed for the first time and divided them into 140 patients of the ACS group and 163 patients of the SAP group.
Compared with patients in the SAP group, patients in the ACS group were younger and had a lower body mass index, higher systolic and diastolic blood pressures, higher estimated GFR, and higher C-reactive protein levels (Table 1) . However, the prevalence of metabolic syndrome did not differ significantly between the ACS group (36.4%) and the SAP group (38.7%). The percentage of patients with estimated GFR <60 mL/min/1.73 m 2 was lower in the ACS group, but the prevalence of CKD did not differ between the ACS group (39.3%) and the SAP group (49.1%; Table 2 ).
A comparison of traditional risk factors (Table 3) showed that the rate of hypertension was lower in the ACS group than in the SAP group but that blood pressures were higher in the ACS group because the rate of medical treatment of hypertension was lower in the ACS group. In particular, the rate of calcium-channel blocker (CCB) treatment was lower in the ACS group (30.7%) than in the SAP group (50.9%, Table 4 ). The rate of hypertriglyceridemia was lower in the ACS group, but the rates of dyslipidemia and of treatment with statins and fibrates did not differ between the groups. The rates of diabetes and obesity did not differ between the groups, but the rate of insulin use was lower in the ACS group. Among traditional risk factors, only current smoking was significantly more frequent in the ACS group (43.6%) than in the SAP group (22.1%, p = 0.00006). When risk factors were adjusted for age and gender, multivariate analysis showed that only current smoking was an independent predictor of ACS (odds ratio 2.20, 95% CI 1.28-3.78; p = 0.004; Table 5 ). Furthermore, among the medications used to treat risk factors, CCBs were identified as possibly having a preventive effect on ACS (odds ratio 0.44, 95% CI 0.26-0.75; p = 0.003), whereas beta-blockers did not (Table 6 ).
Follow-up results
Smoking status could be determined after discharge for 284 patients ( Table 7 ). The ratios of the initial treatment in each group were shown in Table 7 . Background clinical charac- teristics that differed among the 4 smoking-status groups were age, gender, previous ACS, history of malignancy, and initial successful percutaneous coronary intervention. We examined the relationship between smoking status after the initial diagnosis of CAD and the incidence of subsequent cardiac events. The smoking cessation rate from 3 months to 1 year after hospital discharge was 57.7%. The mean follow-up period was 927.2 ± 355.6 days (median, 973 days). The rate of cardiac event-free survival was significantly higher for quitting smokers (94.6%) than for persistent smokers (74.2%, log-rank test, p = 0.004; Fig. 1 ). In fact, the survival rate of quitting smokers was similar to that of former smokers (87.6%, log-rank test, p = 0.131) and never smokers (89.3%, log-rank test, p = 0.177). After adjustment for variables that differed among the 4 groups (age, gender, previous ACS, history of malignancy, and initial successful percutaneous coronary intervention), the risk of cardiac events for persistent smokers was 5 times that for quitting smokers (adjusted hazard ratio 5.05, 95% CI 1. 33-19.20 ; p = 0.02). In other words, smoking cessation after the initial diagnosis of CAD was useful for reducing the risk of recurrent cardiac events (80.2% risk reduction). 
Discussion
Smoking and acute coronary syndrome ACS is a life-threatening disease. If we suffer from atherosclerosis in the coronary artery, it should be avoidable to develop ACS. In the present study, we found that cigarette smoking is an important risk factor for ACS. In other words, our results suggest that cigarette smoking is the ultimate trigger for the onset of ACS rather than SAP. Also, by quitting smoking after CAD is diagnosed, patients can avoid subsequent cardiac events relatively early. In general, to lower the risk of atherosclerosis, all conventional risk factors, including hypertension, dyslipidemia, and diabetes, should be treated and smoking should be ceased. Furthermore, metabolic syndrome and CKD have been identified as risk factors for cardiovascular disease [13] [14] [15] [16] . However, our statistical analysis of all possible risk factors, including metabolic syndrome and CKD, showed that cigarette smoking was the strongest risk factor for ACS.
There are several possible reasons cigarette smoking is so harmful in ACS. Cigarette smoke contains numerous harmful components, including nicotine, carbon monoxide, tar, and carbonyl compounds [26] . Interestingly, smoking alone does not cause the progression of atherosclerosis [2] . In fact, cigarette smoking acts with other risk factors, such as hypercholesterolemia, to accelerate atherosclerosis [2, 27, 28] . Smoking may affect the susceptibility of LDL cholesterol in Fig. 1 Kaplan-Meier survival curves for free from cardiac event according to subsequent smoking status. Persistent smokers had a significantly lower rate of cardiac event-free survival (74.2%) than did quitting smokers (94.6%, log-rank test, p = 0.004).
plasma to peroxidative modification. Modified LDL cholesterol is the preferred substrate for macrophages and induces their subsequent transformation into foam cells [29, 30] . Then, why was cigarette smoking identified as a crucial risk factor for ACS in this study?
Calcium-channel blockers for the primary prevention of acute coronary syndrome
In the present study, we also found that CCBs might be useful for preventing the onset of ACS. Results of previous studies regarding the use of CCBs for treating ischemic heart disease in Caucasian patients have been controversial [31, 32] . However, these studies suggest that CCBs might be useful for preventing the onset of ACS, at least in the present Japanese population. This result regarding primary prevention was similar to that of a previous study on secondary prevention in Japan [33] . Importantly, other agents, including beta-blockers and statins, were not modulating drugs for ACS in this study, although beta-blockers and statins are often considered useful for preventing the progression of coronary atherosclerosis and ischemic heart diseases.
Acute coronary syndrome and coronary spasm
The two main findings of the present study -(1) smoking is a strong risk factor for ACS and (2) CCBs are useful for preventing the development of ACS -support the notion that hypercontractility of the coronary arteries or coronary spasm is strongly associated with the onset of ACS in the Japanese population. In other words, hypercontractility or coronary spasm may be a key mechanism of the onset of ACS in the Japanese population.
Coronary spasm of a major coronary artery is common in the Japanese population and plays an important role in the pathogenesis of variant angina as well as in coronary artery disease in general [34] [35] [36] [37] . Endothelial dysfunction is a key mechanism of coronary spasm; nitric oxide is deficient in the coronary arteries of patients with coronary spasm [37, 38] . Also, as a risk factor for coronary spasm, cigarette smoking is more important than other risk factors [35, 37, 39] .
Several possible mechanisms for the contribution of smoking to ACS can be considered. The key mechanism for the onset of ACS might be endothelial dysfunction induced by smoking on the basis of coronary atherosclerosis. Naturally, endothelial function is reduced by atherosclerosis itself. However, in Japanese patients, endothelial function may be markedly reduced for genetic reasons [40, 41] . Endothelial dysfunction induced by cigarette smoking added to genetic factors induces vascular hypercontractility or coronary spasm [42] . This combination of smoking and genetic factors is probably the reason CCBs were extremely effective in the present study population. Coronary plaques would easily become unstable, and ACS would be likely to occur, in a state of vascular hyperconstriction. Cigarette smoke includes various harmful components; however, for ACS the most important are extracts of oxygen-free radicals, which inactivate nitric oxide and directly damage endothelial cells [26] .
Smoking cessation for the secondary prevention of cardiac events
In the present study, we found that cigarette smoking is an important risk factor for the onset of ACS. Accordingly, smoking cessation has been reported to reduce the risk of subsequent cardiac events and mortality in patients with CAD [4] [5] [6] . Therefore, patients should be encouraged to stop smoking; however, 42.3% of patients with CAD who smoked in the present study could not quit. In the second part of this study, we followed up the smoking status of the patients. Of note, the rate of subsequent cardiac events decreased significantly in quitting smokers during the short follow-up period of 3 years. We speculate that this favorable result was due to improved endothelial function through smoking cessation. Thus, because cigarette smoking is the only risk factor that patients with CAD can avoid by choice, patients with CAD should be strongly encouraged to quit smoking as early as possible for the secondary prevention of cardiac events.
Study limitations
Our study has several limitations that should be considered. First, because some quitting smokers might have resumed smoking, our study might have underestimated the risk reduction associated with stopping smoking. Second, we obtained information regarding smoking status from hospital records, a questionnaire, and interviews of patients, but we did not assess smoking behavior with biochemical tests. Even if a randomized, controlled trial, which would investigate the long-term effects of smoking cessation in patients with newly diagnosed CAD, is ethically problematic, a largescale prospective study in Japan may be required. Finally, in the present study, subjects were patients in whom CAD developed due to a clustering of various risk factors and who received their initial diagnosis of CAD at our hospital. The present study compared characteristics of risk factors between patients with ACS and patients with SAP. Smoking is obviously a risk factor for CAD in general, although Japan's Ministry of Health, Labour and Welfare reported in 2008 that the smoking rate in Japan is 21.8%.
Conclusions
The risk factors were significantly different between ACS and SAP. In conclusion, our comparison of risk factors between ACS and SAP has shown that cigarette smoking is the most important risk factor for ACS among the traditional risk factors, metabolic syndrome, and CKD. Furthermore, among the therapeutic agents used for the primary prevention of CAD, CCBs were underprescribed for many patients with ACS. Treatment with CCBs would probably be effective for preventing ACS in Japanese patients, because CCBs suppress the hypercontractility of the coronary arteries. In the follow-up portion of our study, we found that smoking cessation helped prevent subsequent cardiac events; thus, patients with initially diagnosed CAD should be encouraged to quit smoking as early as possible and should be treated with CCBs.
